Media

2022 H.C. Wainwright BioConnect Conference

WEBCAST

PharmaCyte Biotech, Inc. Annual Meeting of Shareholders June 30, 2021

PharmaCyte Biotech, Inc. Annual Meeting of Shareholders June 16, 2021

Interview with PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, at the GMP Facility

Interview with Austrianova’s Walter H. Gunzburg at the GMP Facility

GMP Manufacturing Facility Walkthrough

CEO Interview: The Big Biz Show

PharmaCyte Biotech Interview with Chief Executive Officer and Chief Scientific Officer – May 30, 2018

Click to listen →

2017 Presentation to Oncologists and Interviews from ASCO Meeting Event in Chicago

Presentation Video:

Dr. Lohr Interview:

Dr. Crabtree Interview:

2017 BIO International Conference Buzz of BIO “Pipelines of Promise” Award Winner Presentation

CEO/CFO Magazine Interview with PharmaCyte CEO & COO

Medical Cannabis for Cancer By Mark L. Rabe, MD

2016 Medical and Scientific Presentations to Clinical Oncologists at ASCO

As PharmaCyte Biotech heads into the final preparations for its Phase 2b clinical trial in advanced pancreatic cancer, the company hosted a medical and scientific discussion of our therapy for advanced pancreatic cancer among top oncologist investigators who have expressed interest in PharmaCyte’s technology and participation in the Phase 2b clinical trial. Below you will find the 5 presentations that were delivered to those invited oncologists. After Dr. Manuel Hidalgo, a member of PharmaCyte’s medical and scientific advisory board, completed his presentation of the design of the upcoming Phase 2b clinical trial, an hour-long discussion took place between those invited oncologists and those representing PharmaCyte Biotech; Dr. Matthias Löhr, Dr. Manuel Hidalgo, Prof. Dr. Walter H. Günzburg, and Dr. Brian Salmons.